logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
C

Clinical and Experimental Rheumatology

IF3.3
Papers231
Citations10524
Journal Papers 15486
Publication Date
delete
Gout: one year in review 2026
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete0
PREAI
deletePunzi, L.; Baggio, C.; Galozzi, P.; Lorenzin, M.; Cozzi, G.; Damasco, A. C.; Sfriso, P.; Oliviero, F.; Ramonda, R.
deleteShare
deleteSave
Belimumab modulates type I interferon signalling in the treatment of systemic lupus erythematosus
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete0
PREAI
deleteXun, T.; Ding, Q.; Ye, Y.; Yang, X.; Mo, L.
deleteShare
deleteSave
The application value of peripheral plasmablasts in the assessment of disease activity and treatment response in systemic lupus erythematosus
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete2
PREAI
deleteWan, L.; Guo, J.; Sun, A.; Chen, H.; Hu, B.; Liu, C.
deleteShare
deleteSave
Drug-induced osteoporosis/osteopenia: a pharmacovigilance analysis using the FDA Adverse Event Reporting System database
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete1
PREAI
deleteWang, Y.; Huang, G.; Fu, X.; Wang, Z.; Mao, W.; Zheng, G.
deleteShare
deleteSave
Patient clustering by serum inflammatory mediators stratifies early disease-modifying anti-rheumatic drug-naive rheumatoid arthritis and reveals distinct pathobiological signatures: a prospective observational cohort
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete0
PREAI
deleteKidoguchi, G.; Ishitoku, M.; Oka, N.; Kobayashi, H.; Hosokawa, Y.; Sugimoto, T.; Yoshida, Y.; Mokuda, S.; Hirata, S.
deleteShare
deleteSave
The application value of peripheral plasmablasts in the assessment of disease activity and treatment response in systemic lupus erythematosus
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete2
PREAI
deleteWan, L.; Guo, J.; Sun, A.; Chen, H.; Hu, B.; Liu, C.
deleteShare
deleteSave
Treatment sequences and lines of therapy in rheumatoid arthritis: a real-world evaluation of retention and effectiveness
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete0
PREAI
deleteMovahedi, M.; Kuriya, B.; Cesta, A.; Li, X.; Aydin, S. Z.; Bombardier, C.; Akhavan, P.
deleteShare
deleteSave
Ultrasensitive serum interleukin-8 levels show no association with disease activity or autoantibody profile but relate to cardiovascular comorbidity in systemic lupus erythematosus
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete1
PREAI
deleteGonzalez-Gay, M. A.; Gomez-Bernal, F.; Heras-Recuero, E.; Quevedo-Abeledo, J. C.; de Vera-Gonzalez, A.; Tejera-Segura, B.; Gomez-Moreno, C.; Garcia-Barrera, E.; Villar, L. M.; Ocejo-Vinyals, J. G.; Largo, R.; Ferraz-Amaro, I.
deleteShare
deleteSave
Cardiac involvement in newly diagnosed patients with idiopathic inflammatory myopathies is associated with skeletal muscle involvement (vol 442, pg 320, 2026)
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete0
PREAI
deleteHanna, B.; Polte, C. L.; Sakiniene, E.; Bollano, E.; Lundberg, I. E.; Pullerits, R.; Jin, T.
deleteShare
deleteSave
Exploring the comorbidity mechanism of rheumatoid arthritis and systemic lupus erythematosus through transcriptomics and conducting experimental validation
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete2
PREAI
deleteShen, Minghui; You, Chongge
deleteShare
deleteSave
Parvovirus B19 infection with rheumatologic manifestations: results from a multicentre Italian study
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete0
PREAI
deleteAldegheri, F.; Bixio, R.; Volpe, A.; Giollo, A.; Fornaro, M.; Morciano, A.; Orlandi, M.; Benini, C.; Biglia, A.; Cassione, E. Bozzalla; Ortolan, A.; Bertelle, D.; Orsolini, G.; Ruzzon, F.; Salvato, M.; Carletto, A.; Campanaro, F.; Chessa, E.; Fracassi, E.; Galvagni, I.; Adami, G.
deleteShare
deleteSave
Resolution of refractory systemic lupus erythematosusassociated alopecia with anifrolumab: a case report
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete0
PREAI
deleteBuscetta, G.; Rizzo, C.; Guggino, G.
deleteShare
deleteSave
Three-year follow-up from a randomised controlled trial of a single intra-articular polyacrylamide hydrogel injection in subjects with knee osteoarthritis
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete2
PREAI
deleteBliddal, H.; Beier, J.; Hartkopp, A.; Conaghan, P. G.; Henriksen, M.
deleteShare
deleteSave
Gout: one year in review 2026
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete0
PREAI
deletePunzi, L.; Baggio, C.; Galozzi, P.; Lorenzin, M.; Cozzi, G.; Damasco, A. C.; Sfriso, P.; Oliviero, F.; Ramonda, R.
deleteShare
deleteSave
Coexistence of sarcoidosis and spondyloarthritis: a rare but intriguing association
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete0
PREAI
deleteAlunno, A.; Carubbi, F.; De Escalante, B.; Policarpo, G.; Retamozo, S.; Morillo, J. S. Garcia; Robles, A.; Atzeni, F.; Ballano, J.; de la Torre, R. Gomez; Dupla, J. M. Lopez; Ramos-Casals, M.; Brito-Zeron, P.
deleteShare
deleteSave
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry (vol 43, pg 1753, 2025)
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete0
PREAI
deleteCalabrese, L.; Cartocci, A.; Vitale, A.; Martin-Nares, E.; D'Onghia, M.; Caggiano, V.; Torres-Ruiz, J.; Lopez, R.; Jahnz-Rozyk, K.; Rybak, K.; Frassi, M.; Franceschini, F.; Crisafulli, F.; Tufan, A.; Kucuk, H.; Guler, A. Avanoglu; Gidaro, A.; Cava, L. La; Casa, F. Della; Mormile, I.; Cinotti, E.; Lopalco, G.; Sota, J.; Sbalchiero, J.; Emmi, G.; Recke, A.; Costi, S.; Sfriso, P.; Monti, S.; Viapiana, O.; Hinojosa-Azaola, A.; Balistreri, A.; Fabiani, C.; Frediani, B.; Rubegni, P.; Wiesik-Szewczyk, E.; Cantarini, L.
deleteShare
deleteSave
Ultrasensitive serum interleukin-8 levels show no association with disease activity or autoantibody profile but relate to cardiovascular comorbidity in systemic lupus erythematosus
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete1
PREAI
deleteGonzalez-Gay, M. A.; Gomez-Bernal, F.; Heras-Recuero, E.; Quevedo-Abeledo, J. C.; de Vera-Gonzalez, A.; Tejera-Segura, B.; Gomez-Moreno, C.; Garcia-Barrera, E.; Villar, L. M.; Ocejo-Vinyals, J. G.; Largo, R.; Ferraz-Amaro, I.
deleteShare
deleteSave
Clinical significance of serum IgE/IgG4 ratio in patients with IgG4-related disease
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete0
PREAI
deleteKwon, O. C.; Park, Y. -B; Park, K. H.; Lee, S. -W
deleteShare
deleteSave
Three-year follow-up from a randomised controlled trial of a single intra-articular polyacrylamide hydrogel injection in subjects with knee osteoarthritis
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete3
PREAI
deleteBliddal, H.; Beier, J.; Hartkopp, A.; Conaghan, P. G.; Henriksen, M.
deleteShare
deleteSave
Patient clustering by serum inflammatory mediators stratifies early disease-modifying anti-rheumatic drug-naive rheumatoid arthritis and reveals distinct pathobiological signatures: a prospective observational cohort
deleteClinical and Experimental Rheumatology
IF3.3
delete2026-05-01
delete0
PREAI
deleteKidoguchi, G.; Ishitoku, M.; Oka, N.; Kobayashi, H.; Hosokawa, Y.; Sugimoto, T.; Yoshida, Y.; Mokuda, S.; Hirata, S.
deleteShare
deleteSave